Additionally, TNC promotes epithelial–mesenchymal transition in nasopharyngeal carcinoma and activates the PI3K/AKT/mTOR signaling pathway, collectively supporting its role as an oncogene [30]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.